NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 871 filers reported holding NOVARTIS A G in Q3 2014. The put-call ratio across all filers is 0.59 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $243,000 | -42.3% | 2,950 | -49.1% | 0.07% | -49.3% |
| Q1 2016 | $421,000 | -21.0% | 5,800 | -6.5% | 0.13% | -8.2% |
| Q4 2015 | $533,000 | -6.5% | 6,200 | 0.0% | 0.15% | -3.3% |
| Q3 2015 | $570,000 | -10.8% | 6,200 | -4.6% | 0.15% | +2.0% |
| Q2 2015 | $639,000 | -0.3% | 6,500 | 0.0% | 0.15% | +0.7% |
| Q1 2015 | $641,000 | +32.4% | 6,500 | +24.4% | 0.15% | +33.6% |
| Q4 2014 | $484,000 | +4.3% | 5,225 | +6.1% | 0.11% | +7.8% |
| Q3 2014 | $464,000 | +4.0% | 4,925 | 0.0% | 0.10% | +4.1% |
| Q2 2014 | $446,000 | +6.4% | 4,925 | 0.0% | 0.10% | -1.0% |
| Q1 2014 | $419,000 | +5.8% | 4,925 | 0.0% | 0.10% | +7.6% |
| Q4 2013 | $396,000 | +4.8% | 4,925 | 0.0% | 0.09% | -2.1% |
| Q3 2013 | $378,000 | +8.6% | 4,925 | 0.0% | 0.09% | +6.8% |
| Q2 2013 | $348,000 | – | 4,925 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANAGED ASSET PORTFOLIOS, LLC | 332,962 | $27,452,000 | 7.32% |
| Mawer Investment Management Ltd. | 7,721,327 | $636,623,000 | 5.86% |
| Martin Investment Management, LLC | 133,246 | $10,986,000 | 5.56% |
| SCHARF INVESTMENTS, LLC | 1,330,175 | $109,673,000 | 5.48% |
| Hansberger Growth Investors, LP | 46,663 | $3,847,000 | 5.19% |
| Bain Capital Public Equity Management II, LLC | 440,233 | $36,297,000 | 4.25% |
| First Fiduciary Investment Counsel, Inc. | 187,633 | $15,470,000 | 4.10% |
| GARLAND CAPITAL MANAGEMENT INC | 53,555 | $4,416,000 | 4.02% |
| Lowell Blake & Associates Inc. | 37,219 | $3,069,000 | 3.94% |
| PRENTISS SMITH & CO INC | 68,027 | $5,609,000 | 3.89% |